With 100% Alcon Ownership, Novartis Forms New Eye Care Unit
This article was originally published in The Gray Sheet
Executive Summary
Novartis will create a new eye care division – representing the fifth growth platform in its health care portfolio – after acquiring full ownership of ophthalmology specialist Alcon.